| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -1.8 | -3.1 |
| EPS (diluted, $ a share) | $-3.19 | $-88.80 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, NASDAQ: ARTL. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Artelo Biosciences, Inc.: key numbers
- Share price
- $1.70Close, Nov 16
- Market cap
- $1.59M
- Shares outstanding
- 937.18KLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Artelo Biosciences, Inc.
All →Artelo Biosciences Nasdaq/NYSE Compliance Notice
Artelo Biosciences was identified as one of approximately 180 companies currently below Nasdaq's new $5 million minimum Market Value of Listed Securities (MVLS) requirement. While the rule is currently under a temporary stay and subject to proposed modifications, the company is monitoring the situation and considering potential actions to maintain compliance, such as capital raises or expense management.
- Counterparty
- Nasdaq